Vesselon (www.vesselon.com) an oncology therapeutics company, announced the acquisition of an FDA-approved drug Imagent. Vesselon will use Imagent to create...
Read more
GlaxoSmithKline announced that the European Commission has granted marketing authorisation for two new methods of administering Nucala (mepolizumab): a pre-filled...
Read more
Daiichi Sankyo Company, Limited announced that the U.S. FDA approved TURALIO as the first and only treatment for adult patients...
Read more
STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its Analytical Service Unit (ASU)...
Read more
IBM and Walmart announced that the companies have been selected by the US FDA to be included in a program...
Read more
Celgene has announced that the US FDA has approved Revlimid (lenalidomide) in combination with rituximab (R2) for patients with previously...
Read more
For an extended time, IBT has consulted with the US FDA on how the company’s planned Phase III study should...
Read more
Impulse Dynamics, developer of the implantable Optimizer Smart System for delivering CCM therapy, announced that the first patient to receive...
Read more
B. Braun Medical Inc. announced the launch of its Heparin Sodium Injection, USP - the first Heparin 5,000 USP Unit...
Read more
Pfizer Inc. announced the United States (U.S.) Food and Drug Administration (FDA) has approved TRAZIMERA„¢ (trastuzumab-qyyp), a biosimilar to Herceptin...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
